412 related articles for article (PubMed ID: 33057040)
1. Systematic analysis of infectious disease outcomes by age shows lowest severity in school-age children.
Glynn JR; Moss PAH
Sci Data; 2020 Oct; 7(1):329. PubMed ID: 33057040
[TBL] [Abstract][Full Text] [Related]
2. Age-Related Differences in Immunological Responses to SARS-CoV-2.
Wong LSY; Loo EXL; Kang AYH; Lau HX; Tambyah PA; Tham EH
J Allergy Clin Immunol Pract; 2020; 8(10):3251-3258. PubMed ID: 32861856
[TBL] [Abstract][Full Text] [Related]
3. [Technical guidelines for seasonal influenza vaccination in China (2020-2021)].
National Immunization Advisory Committee Technical Working Group
Zhonghua Yu Fang Yi Xue Za Zhi; 2020 Oct; 54(10):1035-1059. PubMed ID: 33131228
[TBL] [Abstract][Full Text] [Related]
4. SARS-COV-2 infection in children and newborns: a systematic review.
Liguoro I; Pilotto C; Bonanni M; Ferrari ME; Pusiol A; Nocerino A; Vidal E; Cogo P
Eur J Pediatr; 2020 Jul; 179(7):1029-1046. PubMed ID: 32424745
[TBL] [Abstract][Full Text] [Related]
5. Age-Related Differences in Nasopharyngeal Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Levels in Patients With Mild to Moderate Coronavirus Disease 2019 (COVID-19).
Heald-Sargent T; Muller WJ; Zheng X; Rippe J; Patel AB; Kociolek LK
JAMA Pediatr; 2020 Sep; 174(9):902-903. PubMed ID: 32745201
[TBL] [Abstract][Full Text] [Related]
6. Why the elderly appear to be more severely affected by COVID-19: The potential role of immunosenescence and CMV.
Kadambari S; Klenerman P; Pollard AJ
Rev Med Virol; 2020 Sep; 30(5):e2144. PubMed ID: 32671966
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 Disease Severity Risk Factors for Pediatric Patients in Italy.
Bellino S; Punzo O; Rota MC; Del Manso M; Urdiales AM; Andrianou X; Fabiani M; Boros S; Vescio F; Riccardo F; Bella A; Filia A; Rezza G; Villani A; Pezzotti P;
Pediatrics; 2020 Oct; 146(4):. PubMed ID: 32665373
[TBL] [Abstract][Full Text] [Related]
8. COVID-19, Australia: Epidemiology Report 17 (Fortnightly reporting period ending 24 May 2020).
COVID-19 National Incident Room Surveillance Team
Commun Dis Intell (2018); 2020 Jun; 44():. PubMed ID: 32517645
[TBL] [Abstract][Full Text] [Related]
9. The SARS-CoV-2 Ivermectin Navarra-ISGlobal Trial (SAINT) to Evaluate the Potential of Ivermectin to Reduce COVID-19 Transmission in low risk, non-severe COVID-19 patients in the first 48 hours after symptoms onset: A structured summary of a study protocol for a randomized control pilot trial.
Chaccour C; Ruiz-Castillo P; Richardson MA; Moncunill G; Casellas A; Carmona-Torre F; Giráldez M; Mota JS; Yuste JR; Azanza JR; Fernández M; Reina G; Dobaño C; Brew J; Sadaba B; Hammann F; Rabinovich R
Trials; 2020 Jun; 21(1):498. PubMed ID: 32513289
[TBL] [Abstract][Full Text] [Related]
10. Implications of COVID-19 for an ageing population.
Holt NR; Neumann JT; McNeil JJ; Cheng AC
Med J Aust; 2020 Oct; 213(8):342-344.e1. PubMed ID: 32946607
[No Abstract] [Full Text] [Related]
11. COVID-19 in Children in the United States: Intensive Care Admissions, Estimated Total Infected, and Projected Numbers of Severe Pediatric Cases in 2020.
Pathak EB; Salemi JL; Sobers N; Menard J; Hambleton IR
J Public Health Manag Pract; 2020; 26(4):325-333. PubMed ID: 32282440
[TBL] [Abstract][Full Text] [Related]
12. Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide.
Ayoub HH; Chemaitelly H; Seedat S; Mumtaz GR; Makhoul M; Abu-Raddad LJ
PLoS One; 2020; 15(8):e0237959. PubMed ID: 32817662
[TBL] [Abstract][Full Text] [Related]
13. COVID-19 Is Distinct From SARS-CoV-2-Negative Community-Acquired Pneumonia.
Zhou Y; Guo S; He Y; Zuo Q; Liu D; Xiao M; Fan J; Li X
Front Cell Infect Microbiol; 2020; 10():322. PubMed ID: 32612961
[No Abstract] [Full Text] [Related]
14. Characteristics in Pediatric Patients with Coronavirus Disease 2019 in Korea.
Seon JY; Jeon WH; Bae SC; Eun BL; Choung JT; Oh IH
J Korean Med Sci; 2021 May; 36(20):e148. PubMed ID: 34032033
[TBL] [Abstract][Full Text] [Related]
15. SARS - CoV-2: Reasons of epidemiology of severe ill disease cases and therapeutic approach using trivalent vaccine (tetanus, diphtheria and Bordetella pertussis).
Ietto G
Med Hypotheses; 2020 Aug; 141():109779. PubMed ID: 32387756
[TBL] [Abstract][Full Text] [Related]
16. Coronavirus global pandemic: An overview of current findings among pediatric patients.
Perikleous E; Tsalkidis A; Bush A; Paraskakis E
Pediatr Pulmonol; 2020 Dec; 55(12):3252-3267. PubMed ID: 32965785
[TBL] [Abstract][Full Text] [Related]
17. Lessons From COVID-19 in Children: Key Hypotheses to Guide Preventative and Therapeutic Strategies.
Singh T; Heston SM; Langel SN; Blasi M; Hurst JH; Fouda GG; Kelly MS; Permar SR
Clin Infect Dis; 2020 Nov; 71(8):2006-2013. PubMed ID: 32382748
[TBL] [Abstract][Full Text] [Related]
18. Evaluating the Effectiveness of Social Distancing Interventions to Delay or Flatten the Epidemic Curve of Coronavirus Disease.
Matrajt L; Leung T
Emerg Infect Dis; 2020 Aug; 26(8):1740-1748. PubMed ID: 32343222
[TBL] [Abstract][Full Text] [Related]
19. Pathophysiology of COVID-19: Why Children Fare Better than Adults?
Dhochak N; Singhal T; Kabra SK; Lodha R
Indian J Pediatr; 2020 Jul; 87(7):537-546. PubMed ID: 32410003
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in children: current evidence and key questions.
Munro APS; Faust SN
Curr Opin Infect Dis; 2020 Dec; 33(6):540-547. PubMed ID: 33027185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
